Effect of Inspiratory Muscle Training on Symptom Severity and Quality of Life in Non-Erosive Reflux Disease
Key facts
- Who runs it
- Izmir University of Economics
- Where
- Türkiye1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 60 people, planned
- Started
- 22 Jul 2026
- Expected to end
- 15 May 2027
- Type of study
- Interventional, 2 groupsOne group gets a sham (pretend) treatment, for comparison.
- Treatments tested
- Inspiratory Muscle Training (IMT)
- Sham IMT
- Record updated
- 24 June 2026
Who can take part
- Age
- 18 years to 65 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 18 criteriaShow less
Who can take part
- A clinical diagnosis of NERD,
- No erosive lesions on endoscopy,
- Presence of reflux symptoms for at least 3 months
Who cannot take part
- Current use of proton pump inhibitors (PPIs) or failure to complete a minimum 2-week washout period before enrollment
- With a history of gastrointestinal malignancy
- With infectious or inflammatory gastrointestinal diseases
- With malabsorption syndrome or gastrointestinal obstruction
- With a history of major gastrointestinal surgery (including anti-reflux, gastric, or duodenal surgery)
- With systemic sclerosis or other systemic connective tissue diseases
- With severe cardiovascular, pulmonary, renal, or hepatic disease
- With chronic respiratory diseases such as asthma or COPD
- Having had an acute respiratory tract infection within the past 4 weeks
- With neuromuscular diseases
- With active tuberculosis
- With known gastroduodenal ulcers
- Diagnosed with erosive esophagitis
- With hiatal hernia
- Pregnancy
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 18 and 65 years old?
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical trial is to learn if inspiratory muscle training (IMT) works to treat on clinical symptom severity and quality of life in patients with Non-erosive reflux disease (NERD). The main questions it aims to answer are:
Read full original descriptionShow less
Does drug IMT lower the clinical symptom severity ? Does drug IMT improve quality of life? Researchers will compare high intensity IMT to a sham-IMT (a IMT device with no resistance) to see if IMT lower the clinical symptom severity and improve improve quality of life.
Participants will perform the following protocol:
The IMT protocol will consist of home-based high-intensity training using a Threshold IMT device: two sets of 30 breaths with a 1-minute rest, twice daily for 4 weeks. The study group will train at 60% of baseline maximum inspiratory pressure (MIP), with weekly adjustments based on modified Borg scores (4-6), while the control group will perform sham IMT without resistance.
The 2 groups in the trial
- Study GroupTreatment being tested
Patients who will perform inspiratory muscle training (IMT) with %60 loading
Treatment: Inspiratory Muscle Training (IMT)
- Sham GroupSham treatment, for comparison
Patients who will perform Sham IMT
Treatment: Sham IMT
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Effect of Inspiratory Muscle Training on Clinical Symptom Severity and Quality of Life in Patients With Non-erosive Reflux Disease: A Randomized Controlled Trial
- Criteria questions
- Built from NCT07584096, who can take part
- Record updated
- 24 June 2026